Nguyen BY, Reveille JD. (2009) Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era. Current Opinion Rheumatology. 2009 Jul;21(4):404-10

Wit, F; Weverling, G; et al. (2002) Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination Therapy. The Journal of Infectious Diseases 2002;186:23–31

Moyle G; Sawyer W; Law M; Amin J; Hill A. (2004) Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies. Clinical Therapy. 2004 Jan;26(1):92-7.

Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis (2005) Morbidity and Mortality Weekly Report. September 30, 2005 / Vol. 54 / No. RR-9

HIV and Its Treatment: What You Should Know: Health Information for Patients (2006). U.S. Department of Health and Human Services.
Http://www.aidsinfo.nih.gov

Center for Disease Control and Prevention. Morbidity and Mortality Weekly Report. Recommendations and Reports. December 5, 2008/57. Appendix A. AIDS-Defining Conditions.
Accessed 6/8/2008 http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5710a2.htm

Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents.
Department of Health and Human Services. November 3, 2008; 1-139.
Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
Accessed 6/1/09

Public Health Service Task Force. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. April 29, 2009 Release. Available at http://aidsinfo.nih.gov/contentfiles/Peri_Tables.pdf Accessed 6/1/09

Lesho, E.P., & Gey, D.C. (2003). Managing issues related to antiretroviral therapy. American Family Physician, 68 (4), 675-686

National Institute of Allergy and Infectious Diseases. (2005). HIV Infection and AIDS: An Overview. www.niaid.nih.gov/factsheets/hivinf

National Institute of Allergy and Infectious Diseases. (2006). Treatment of HIV Infection. www.niaid.nih.gov/factsheets/treat-hiv.htm

National Institute of Allergy and Infectious Diseases. (2003). New Treatment for HIV Infection: Prolonging and Improving Life. www.niaid.nih.gov/publications/discovery

National Institute of Allergy and Infectious Diseases. (2004). How HIV Causes Aids Infection. www.niaid.nih.gov/factsheets/howhiv

U.S. Department of Health and Human Services. (2004). Side Effects of Anti-HIV Medications.
http://aidsinfo.nih.gov/other/sideeffectshiv/english/sideeffectshiv_en.html

Mayo Clinic. (2006). HIV/AIDS – Treatment. www.mayoclinic.com

Catanzaro, L. (2006). Antiretroviral Quick Guide. HIV ePharmacotherapy Network. School of Pharmacy and Pharmaceutical Sciences University at Buffalo
http://hiv.buffalo.edu/adherence-quickguide.shtml

Watts DH, Covington DL et al. (2004) Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy. American Journal of Obstetrics and Gynecology, Volume 191, Issue 3, Pages 985-992

Townsend, C.; Cortina-Borja, M.; et al. (2007) Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in theUnited Kingdom and Ireland. AIDS 2007, 21:1019–1026

Townsend, C; Willey, B; et al. (2009) Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007

SUSTIVA (efavirenz) HIGHLIGHTS OF PRESCRIBING INFORMATION (2009) Bristol-Myers Squibb.